Show notes at pharmacyjoe.com/episode922. In this episode, I’ll discuss assessing the risk of bias in a review of nonrandomized studies.

Show notes at pharmacyjoe.com/episode921. In this episode, Ill discuss what if it is not the sedative class that causes delirium just the depth of sedation?

Show notes at pharmacyjoe.com/episode920. In this episode, Ill discuss what blood gas parameters can make you suspect methemoglobinemia.

Show notes at pharmacyjoe.com/episode919. In this episode, Ill discuss the problem with hypo-osmolar solutions in neurological patients.

Show notes at pharmacyjoe.com/episode918. In this episode, Ill discuss the impact of giving a full-dose cephalosporin challenge to patients with a moderate, severe, or unknown beta-lactam allergy.

Show notes at pharmacyjoe.com/episode917. In this episode, Ill discuss the impact of achieving an aggressive PK/PD target for beta lactams in critically ill patients.

Show notes at pharmacyjoe.com/episode916. In this episode, Ill discuss the 4 categories of interventions to treat medication overdose and why antidote is not #1.

Show notes at pharmacyjoe.com/episode915. In this episode, Ill discuss the rare case when a very hypotonic solution may be indicated.

Show notes at pharmacyjoe.com/episode914. In this episode, Ill discuss oral vs IV phosphate replacement for critically ill patients with mild to moderate hypophosphatemia.

Show notes at pharmacyjoe.com/episode913. In this episode, Ill discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.